"'예쁜 치매'를 위해… 지친 가족부터 어루만져야" naver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from naver.com Daily Mail and Mail on Sunday newspapers.
Trial studying antidepressant s possible role in COVID-19 treatment after discovery by UVA doctor
and last updated 2021-01-27 22:26:56-05
CHARLOTTESVILLE, Va. - A clinical trial is underway to test whether a common drug may help treat COVID-19 following a discovery by a doctor at the University of Virginia School of Medicine.
âIt s kind of a dream for every scientist to make a discovery that can impact human health,â Dr. Alban Gaultier, Neuroscience Professor at University of Virginia School of Medicine told News 3. âIt was kind of by accident.â
Gaultier said the discovery involved the antidepressant, fluvoxamine, also known as Luvox, capable of possibly stopping sepsis.
This week, a federal judge in Texas has blocked President Joe Biden’s attempt to stop deportations. Elissa Steglich, a co-director and professor at the University of Texas Immigration Clinic at the UT School of Law in Austin, talks to the Standard.
For some COVID-19 patients, a negative test does not mean that they’re done with the virus. It’s called long-haul COVID, when symptoms like chronic fatigue, respiratory problems, and brain fog can persist for months after contracting the virus. Although doctors know more about long-haul COVID than when the pandemic started, there are still lots of questions about its effects. Dr. Esther Melamed, an assistant Neurology Professor at UT-Austin’s Dell Medical School, talks to the Standard.
Scientists discover mechanism for transient memory lapse
In a landmark neurobiology study, scientists from Scripps Research have discovered a memory gating system that employs the neurotransmitter dopamine to direct transient forgetting, a temporary lapse of memory which spontaneously returns.
The study adds a new pin to scientists evolving map of how learning, memory and active forgetting work, says Scripps Research Neuroscience Professor Ron Davis, Ph.D.
This is the first time a mechanism has been discovered for transient memory lapse. There s every reason to believe, because of conservation biology, that a similar mechanism exists in humans as well.
Ron Davis, Ph.D., Neuroscience Professor, Scripps Research